Nephro Care India (NSE:NEPHROCARE) ROCE %: 2.25% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NEPHROCARE Nephro Care India Ltd NSE:NEPHROCARE
48 GF Score
Price ₹93.75
! 2 Warning Signs
View Full Analysis

What is Nephro Care India ROCE %?

Nephro Care India NSE:NEPHROCARE +2.29% 48 ROCE % is 2.25% as of Mar. 2026. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nephro Care India's annualized ROCE % for the quarter that ended in Mar. 2026 was 2.25%.

Nephro Care India  (NSE:NEPHROCARE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nephro Care India ROCE % Related Terms

Nephro Care India ROCE % Historical Data

* Premium members only.

The historical data trend for Nephro Care India's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nephro Care India ROCE % Chart

Nephro Care India Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 0.83 71.19 62.29 13.96 8.41

Nephro Care India Semi-Annual Data
Mar21 Mar22 Mar23 Dec23 Mar24 Sep24 Mar25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.06 2.25
NSE:NEPHROCARE
48GF Score
Nephro Care India Ltd NSE:NEPHROCARE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nephro Care India ROCE % Calculation

Nephro Care India's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=46.969/( ( (682.845 - 140.312) + (727.209 - 152.753) )/ 2 )
=46.969/( (542.533+574.456)/ 2 )
=46.969/558.4945
=8.41 %

Nephro Care India's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=12.919/( ( (0 - 0) + (727.209 - 152.753) )/ 1 )
=12.919/( ( 0 + 574.456 )/ 1 )
=12.919/574.456
=2.25 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.25% mean?
Nephro Care India (NSE:NEPHROCARE) has a ROCE % of 2.25% as of Mar. 2026.
Is Nephro Care India's ROCE % too high?
Nephro Care India's current ROCE % is 2.25%. The Healthcare Providers & Services industry median ROCE % is 6.32. Nephro Care India's value of 2.25% is 64.4% below this industry median. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's ROCE % compare to HCA and THC?
Nephro Care India's ROCE % of 2.25% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.32. Nephro Care India's value of 2.25% is 64.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.32, based on 654 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nephro Care India's current ROCE % of 2.25% is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nephro Care India's current ROCE % is 2.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current ROCE % of 2.25%. The current ROCE % is 2.25% and 64.4% below the Healthcare Providers & Services industry median of 6.32. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current ROCE % is 2.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nephro Care India Business Description

Address c/o EFC India - Millenium City IT Park, Tower 2, 12th Floor, DN 62, DN Block, Sector V, Bidhannagar, Kolkata, WB, IND, 700091
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score

Get the complete analysis for NSE:NEPHROCARE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹93.75
Price